SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 02, 2022
Share
SYN-TECH Chem. & Pharm. Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 281.81 million compared to TWD 180.15 million a year ago. Net income was TWD 113.33 million compared to TWD 25.12 million a year ago. Basic earnings per share from continuing operations was TWD 2.54 compared to TWD 0.73 a year ago. Diluted earnings per share from continuing operations was TWD 2.54 compared to TWD 0.73 a year ago.
For the nine months, sales was TWD 738.25 million compared to TWD 748.87 million a year ago. Net income was TWD 271.99 million compared to TWD 131.06 million a year ago. Basic earnings per share from continuing operations was TWD 6.1 compared to TWD 3.79 a year ago. Diluted earnings per share from continuing operations was TWD 6.09 compared to TWD 3.79 a year ago.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Company's main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.